SCHEMBL12731474

SCHEMBL12731474

c1ccc(-n2c3ccccc3c3c4ccc5ccc(-c6ccc(-c7cn8cccnc8n7)cc6)c6ccc(cc32)c4c56)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 16/20 0.49
▸ KDM4E B2RXH2 15/20 0.49
▸ HPGD P15428 9/20 0.49
▸ GLA P06280 6/20 0.49
▸ HSD17B10 Q99714 4/20 0.49
▸ RAB9A P51151 13/20 0.44
▸ GAA P10253 9/20 0.44
▸ NPC1 O15118 9/20 0.44
▸ SMN1; SMN2 Q16637 7/20 0.44
▸ MAPT P10636 7/20 0.44
▸ KMT2A Q03164 5/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ TP53 P04637 2/20 0.44
▸ POLB P06746 3/20 0.42
▸ CDC7 O00311 1/20 0.41
▸ DAPK3 O43293 1/20 0.41
▸ DYRK3 O43781 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ PRKD3 O94806 1/20 0.41
▸ CDK1 P06493 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14330569 0.92 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL14330521 0.92 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL12731473 0.87 RAB9A (0.43) ALDH1A1KDM4EHPGDHSD17B10RAB9A
SCHEMBL4469310 0.80 ALDH1A1 (0.58) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL17658826 0.79 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL2627516 0.79 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL10034187 0.79 KDM4E (0.33) KDM4E
SCHEMBL2601512 0.79 KDM4E (0.33) KDM4E
SCHEMBL15803051 0.78 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDGLAHSD17B10
SCHEMBL15803103 0.78 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDGLAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308843-B1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER CONTAINING THE CONDENSED-CYCLIC COMPOUND SAMSUNG DISPLAY CO LTD (KR) 2016-12-14 — — EP disclosed
US-9000420-B2 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-07 — — US disclosed
US-9000420-B2 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-07 — — US disclosed
US-20110084256-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER CONTAINING THE CONDENSED-CYCLIC COMPOUND SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-04-14 — — US disclosed
US-20110084256-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER CONTAINING THE CONDENSED-CYCLIC COMPOUND SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-04-14 — — US disclosed
EP-2308843-A1 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound Samsung Mobile Display Co., Ltd. (KR) 2011-04-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110084256-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER CONTAINING THE CONDENSED-CYCLIC COMPOUND CCNL2, C9, OCIAD1 ALDH1A1 417/4885KDM4E 3667/4885HPGD 1897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback